Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Ophthalmic Research|March 17, 2016
Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy: A Comparative AnalysisKapil G Kapoor, Alan L WagnerCase Reports in Ophthalmology|March 9, 2016
Eplerenone in the Treatment of Polypoidal Choroidal VasculopathyKapil G Kapoor, Alan L WagnerOphthalmology and Therapy|December 1, 2016
Mineralocorticoid Antagonists as Adjuncts in Neovascular Age-Related Macular DegenerationKapil G Kapoor, Niket Todi, Alan L WagnerCase Reports in Ophthalmology|June 14, 2016
Intravitreal Daptomycin for Recalcitrant Postoperative EndophthalmitisJennifer M Sim, Kapil G Kapoor, Alan L WagnerSeminars in Ophthalmology|February 12, 2021
Ziv-aflibercept for Better Regulating Neovascular Age-Related Macular Degeneration (ZEBRA): A Prospective, Randomized TrialHaley S D'Souza, Kapil G Kapoor, Alan L WagnerOphthalmic Surgery, Lasers & Imaging Retina|December 20, 2018
Updated Cost-Effectiveness of Intravitreal Ocriplasmin for Vitreomacular Adhesion and Macular HoleTayab Waseem, Colin Reinhart, Alan L Wagner, et al.Ocular Immunology and Inflammation|August 17, 2019
Successful Clinical Outcome of Vancomycin-induced Hemorrhagic Occlusive Retinal VasculitisGuneet S Sodhi, Quentin J Franklin, Alan L Wagner, et al.Seminars in Ophthalmology|July 18, 2019
Intravitreal Ziv-Aflibercept: A Comprehensive ReviewDaniel Barmas-Alamdari, Haley S D'Souza, Kapil G Kapoor, et al.Plos One|September 14, 2020
Differences in characteristics of Medicare patients treated by ophthalmologists and optometristsDarby D Miller, Michael W Stewart, Joshua J Gagne, et al.Journal of Comparative Effectiveness Research|January 22, 2020
Cost-effectiveness analysis of ocriplasmin versus watchful waiting for treatment of symptomatic vitreomacular adhesion in the USArshad M Khanani, Pravin U Dugel, Julia A Haller, et al.Pageof 2